5 primary shifts in managing chronic pain and depression in 2026 In 2026, the medical community is moving toward a "unified theory" of pain and mood, recognizing that these two conditions often share the same neural pathways. This shift is leading to a significant increase in the use of dual-reuptake inhibitors as a primary treatment for fibromyalgia and other central sensitization syndromes. By addressing the neurochemical imbalances that amplify pain...